In 2012, Mitomed developed an interest in mitochondrial medicine and began conducting research, as mitochondria may hold the key to cellular aging and regeneration. Subsequent studies revealed that the principle behind stem cell therapy also stems from mitochondrial transfer. Mitomed later founded a company to continue researching and developing related mitochondrial medical technologies. To date, it has created multiple technology platforms applicable to cell therapy, neural repair, pharmaceuticals, and anti-aging. Mitomed takes pride in being a pioneer in mitochondrial medicine worldwide.